Edges in Network
Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | SLC25A37 |
Upstream (Parents) |
---|
(<<) ACTN1 → SLC25A37 |
(<<) ADAM17 → SLC25A37 |
(<<) CHST12 → SLC25A37 |
(<<) EIF2C2 → SLC25A37 |
(<<) EML4 → SLC25A37 |
(<<) FZD4 → SLC25A37 |
(<<) HIPK1 → SLC25A37 |
(<<) MAP3K2 → SLC25A37 |
(<<) NOL9 → SLC25A37 |
(<<) PDPK1 → SLC25A37 |
(<<) PIK3CA → SLC25A37 |
(<<) PLOD2 → SLC25A37 |
(<<) PRKCH → SLC25A37 |
(<<) PRKCI → SLC25A37 |
(<<) RCAN1 → SLC25A37 |
(<<) RXRB → SLC25A37 |
(<<) STAT3 → SLC25A37 |
(<<) THOC4 → SLC25A37 |
(<<) TK2 → SLC25A37 |
Downstream (Children) |
---|
SLC25A37 → ARID3B (>>) |
SLC25A37 → CASP9 (>>) |
SLC25A37 → CDR2 (>>) |
SLC25A37 → DDX18 (>>) |
SLC25A37 → ERRFI1 (>>) |
SLC25A37 → FA2H (>>) |
SLC25A37 → GNB4 (>>) |
SLC25A37 → GRB10 (>>) |
SLC25A37 → INSR (>>) |
SLC25A37 → ITPR2 (>>) |
SLC25A37 → KCNJ2 (>>) |
SLC25A37 → LRP5 (>>) |
SLC25A37 → MAP6D1 (>>) |
SLC25A37 → MEF2A (>>) |
SLC25A37 → MOBKL2C (>>) |
SLC25A37 → MT1F (>>) |
SLC25A37 → MT1G (>>) |
SLC25A37 → MT1P2 (>>) |
SLC25A37 → PFDN2 (>>) |
SLC25A37 → PI3 (>>) |
SLC25A37 → PPP3CB (>>) |
SLC25A37 → SLC6A14 (>>) |
SLC25A37 → SLPI (>>) |
SLC25A37 → SOD2 (>>) |
SLC25A37 → SPATA2L (>>) |
SLC25A37 → STX1A (>>) |
SLC25A37 → TM4SF1 (>>) |
SLC25A37 → TSPAN10 (>>) |
SLC25A37 → WWTR1 (>>) |